- Home
- PCRX vs INVX Comparison
PCRX vs INVX Comparison
Compare PCRX & INVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- INVX
- Stock Information
- Founded
- PCRX 2006
- INVX 2024
- Country
- PCRX United States
- INVX United States
- Employees
- PCRX N/A
- INVX N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- INVX
- Sector
- PCRX Health Care
- INVX
- Exchange
- PCRX Nasdaq
- INVX NYSE
- Market Cap
- PCRX 1.2B
- INVX 1.2B
- IPO Year
- PCRX 2011
- INVX N/A
- Fundamental
- Price
- PCRX $22.07
- INVX $15.76
- Analyst Decision
- PCRX Buy
- INVX Hold
- Analyst Count
- PCRX 8
- INVX 2
- Target Price
- PCRX $28.38
- INVX $16.50
- AVG Volume (30 Days)
- PCRX 590.9K
- INVX 389.9K
- Earning Date
- PCRX 08-05-2025
- INVX 08-05-2025
- Dividend Yield
- PCRX N/A
- INVX N/A
- EPS Growth
- PCRX N/A
- INVX 19.36
- EPS
- PCRX N/A
- INVX 2.31
- Revenue
- PCRX $702,772,000.00
- INVX $773,221,000.00
- Revenue This Year
- PCRX $7.90
- INVX $41.72
- Revenue Next Year
- PCRX $11.02
- INVX $2.27
- P/E Ratio
- PCRX N/A
- INVX $6.83
- Revenue Growth
- PCRX 3.08
- INVX 42.69
- 52 Week Low
- PCRX $11.16
- INVX $11.93
- 52 Week High
- PCRX $27.64
- INVX $19.42
- Technical
- Relative Strength Index (RSI)
- PCRX 44.39
- INVX N/A
- Support Level
- PCRX $20.85
- INVX N/A
- Resistance Level
- PCRX $22.32
- INVX N/A
- Average True Range (ATR)
- PCRX 0.84
- INVX 0.00
- MACD
- PCRX 0.01
- INVX 0.00
- Stochastic Oscillator
- PCRX 44.69
- INVX 0.00
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
About INVX INNOVEX INTERNATIONAL INC
Innovex International Inc designs, manufactures, sells, and rents mission-critical engineered products to the oil and natural gas industry. Its products are Subsea, Surface Wellheads, Well Construction, Well Completion, Production Solutions, Fishing & Intervention. Its products support upstream onshore and offshore activities. The group's geographic regions are North America, Latin America, Middle East & Asia Pacific, and Europe & Africa.